Spruce Biosciences, Inc. (NASDAQ:SPRB) Sees Significant Drop in Short Interest

Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 52,300 shares, a decline of 24.0% from the November 15th total of 68,800 shares. Based on an average daily trading volume, of 122,900 […]

Related Keywords

Canada , ,Dimensional Fund Advisors ,Spruce Biosciences Inc ,Privium Fund Management ,Royal Bank ,Nasdaq ,Charles Schwab Investment Management Inc ,Spruce Biosciences ,Get Free Report ,Schwab Investment Management ,Sigma Advisers ,Fund Advisors ,Spruce Biosciences Daily ,Nasdaq Sprb ,Isprb ,Medical ,Stocks ,Options ,Put ,Call ,